Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Accell TBM
- Development stage
- Unknown
- Lead developer
- Orthofix
- Administration
- Topical
01
Overview
Accell TBM (Total Bone Matrix) is a demineralized bone matrix (DBM) product used as a bone graft substitute in orthopedic and spinal procedures. Originally developed by IsoTis Inc. and currently marketed by Orthofix (following its association with Integra LifeSciences and SeaSpine), it is composed of demineralized human bone. The product is unique for being a moldable DBM graft created through a proprietary process that does not require an inert carrier or plasticizer, ensuring the entire matrix is osteoconductive with osteoinductive potential. It is primarily indicated as a bone graft extender or bone void filler in the spine, extremities, and pelvis, often serving as an alternative to autologous bone harvesting from the iliac crest.
- Brand names
- Accell TBM
- Other names
- Accell Total Bone Matrix
02
Targets
BMPR (Bone morphogenetic protein receptor)BMP (Bone morphogenetic protein family)
Beyond the preview
Go deeper on Accell TBM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Accell TBM.